valine and Triple Negative Breast Neoplasms

valine has been researched along with Triple Negative Breast Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chiu, SY; Chung, HJ; Huang, CC; Huang, MS; Lin, Y; Liu, F; Matsuura, I; Yadav, P	1
Ching, K; Christensen, J; Li, D; Li, X; Olson, P; Ozeck, M; Rejto, P; Shi, S; Wang, H; Wang, K; Zhang, C; Zhang, Q; Zheng, X	1
Aftimos, P; Awada, A; Cesari, R; Curigliano, G; Dees, EC; Huang, B; Jiang, Y; Kern, KA; Locatelli, MA; LoRusso, PM; Pegram, MD; Shaik, MN	1

Trials

1 trial(s) available for valine and Triple Negative Breast Neoplasms

Article	Year
Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer. Oncotarget, 2017, Jan-10, Volume: 8, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Tetrahydronaphthalenes; Triple Negative Breast Neoplasms; Valine; Vomiting	2017

Article

Year

Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer.

Oncotarget, 2017, Jan-10, Volume: 8, Issue:2

Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neutropenia; Taxoids; Tetrahydronaphthalenes; Triple Negative Breast Neoplasms; Valine; Vomiting

2017

Other Studies

2 other study(ies) available for valine and Triple Negative Breast Neoplasms

Article	Year
Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site. Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:11 Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Female; Gene Editing; Gene Knock-In Techniques; Humans; Lung Neoplasms; Mice; Mice, SCID; Phosphorylation; Point Mutation; Signal Transduction; Smad3 Protein; Threonine; Transforming Growth Factor beta; Triple Negative Breast Neoplasms; Valine; Xenograft Model Antitumor Assays	2018
PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor. Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Mar-15, Volume: 21, Issue:6 Topics: Algorithms; Amyloid Precursor Protein Secretases; Animals; Base Sequence; Cell Line, Tumor; Cell Proliferation; Computational Biology; DNA Copy Number Variations; Female; Gene Dosage; Humans; Mice; Mice, SCID; Protein Structure, Tertiary; Receptor, Notch1; Receptor, Notch2; Receptor, Notch3; Receptors, Notch; Sequence Analysis, DNA; Signal Transduction; Tetrahydronaphthalenes; Triple Negative Breast Neoplasms; Valine; Xenograft Model Antitumor Assays	2015

Article

Year

Impaired mammary tumor formation and metastasis by the point mutation of a Smad3 linker phosphorylation site.

Biochimica et biophysica acta. Molecular basis of disease, 2018, Volume: 1864, Issue:11

Topics: Animals; Binding Sites; Cell Line, Tumor; Cell Proliferation; Female; Gene Editing; Gene Knock-In Techniques; Humans; Lung Neoplasms; Mice; Mice, SCID; Phosphorylation; Point Mutation; Signal Transduction; Smad3 Protein; Threonine; Transforming Growth Factor beta; Triple Negative Breast Neoplasms; Valine; Xenograft Model Antitumor Assays

2018

PEST domain mutations in Notch receptors comprise an oncogenic driver segment in triple-negative breast cancer sensitive to a γ-secretase inhibitor.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2015, Mar-15, Volume: 21, Issue:6

Topics: Algorithms; Amyloid Precursor Protein Secretases; Animals; Base Sequence; Cell Line, Tumor; Cell Proliferation; Computational Biology; DNA Copy Number Variations; Female; Gene Dosage; Humans; Mice; Mice, SCID; Protein Structure, Tertiary; Receptor, Notch1; Receptor, Notch2; Receptor, Notch3; Receptors, Notch; Sequence Analysis, DNA; Signal Transduction; Tetrahydronaphthalenes; Triple Negative Breast Neoplasms; Valine; Xenograft Model Antitumor Assays

2015